Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Helen Leis

Partner, Health and Life Sciences, Oliver Wyman

Hospitals nationwide could near collapse as the pandemic straps them of necessary resources.

Partner & Co-Head – Risk & Public Policy, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

New Predictions on COVID-19 Vaccines and Herd Immunity

How COVID-19 case counts and vaccines may get us back to normalcy by June.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

New Oliver Wyman analysis on when and how a vaccine may be available and key considerations for how to reach herd immunity.

CEO, Independent Grocers Alliance
Partner, Health and Life Sciences, Oliver Wyman

The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

Returning to work, school, and daily life in a recovering economy means co-existing with COVID-19.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Q&A with a Pandemic Response Expert

How COVID-19 testing, contact tracing, and targeted quarantine may revive consumer and employee confidence.

Partner, Health and Life Sciences, Oliver Wyman

As parts of the nation begin to re-open, new considerations are unfolding that leaders struggle to manage.

Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Key takeaways for navigating COVID-19 as lockdowns are lifted and economies are reopened.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Businesses must prepare now for the long haul of COVID-19 suppression if they are to survive in a changed economy.

Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Evaluating healthcare workforce supply and demand.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe